Noven Therapeutics is recalling approximately 41,836 boxes of Daytrana (methylphenidate transdermal system) patches across four different dosage strengths. The patches, which are used to treat ADHD, are being recalled because they failed mechanical testing for peel and shear strength, meaning the delivery system may not work as intended. Consumers who use these patches should contact their healthcare provider or pharmacist for guidance regarding their treatment.
The delivery system is out of specification for mechanical peel and shear, which could affect how the patch adheres to the skin or how the medication is released, potentially resulting in incorrect dosing or ineffective treatment.
Healthcare provider consultation and pharmacy return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.